A multi-targeting bionanomatrix coating to reduce capsular contracture development on silicone implants
P Hwang, CM Shin, JA Sherwood, DH Kim… - Biomaterials …, 2023 - spj.science.org
Background Capsular contracture is a critical complication of silicone implantation caused
by fibrotic tissue formation from excessive foreign body responses. Various approaches …
by fibrotic tissue formation from excessive foreign body responses. Various approaches …
Enhanced Endothelialization Using Resveratrol-Loaded Polylactic Acid-Coated Left Atrial Appendage Occluders in a Canine Model
L Hu, K Zhang, H Zhang, X Dong, L Ding… - ACS Applied Bio …, 2025 - ACS Publications
Left atrial appendage occlusion (LAAO) is a well-established alternative to anticoagulation
therapy for patients with atrial fibrillation who have a high bleeding risk. After occluder …
therapy for patients with atrial fibrillation who have a high bleeding risk. After occluder …
Incidence, impact and predictors of residual device patency after left atrial appendage closure with the LACbes device
PC Yao, ZT Fei, M Chen, BF Mo, R Zhang… - International Journal of …, 2024 - Elsevier
Background The residual device patency (RDP) after left atrial appendage closure (LAAC)
with the LACbes device has not been specifically explored in atrial fibrillation (AF) patients …
with the LACbes device has not been specifically explored in atrial fibrillation (AF) patients …
[HTML][HTML] Comparative Endothelialization of the Watchman Plug Device and LACBES Pacifier Occluder after Left Atrial Appendage Closure
J Zhou, Z Zhang, K Zhang, T Zhang… - Reviews in …, 2024 - pmc.ncbi.nlm.nih.gov
Background: For patients with nonvalvular atrial fibrillation (NVAF), left atrial appendage
closure (LAAC) is an alternative to oral anticoagulants (OACs). However, incomplete device …
closure (LAAC) is an alternative to oral anticoagulants (OACs). However, incomplete device …